Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 227, Issue 2, Pages 146-156
Publisher
Wiley
Online
2012-02-24
DOI
10.1002/path.4006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
- (2011) Hiroto Izumi et al. CANCER SCIENCE
- Evidence for a stromal-epithelial “lactate shuttle” in human tumors
- (2011) Diana Whitaker-Menezes et al. CELL CYCLE
- Metabolic Flux and the Regulation of Mammalian Cell Growth
- (2011) Jason W. Locasale et al. Cell Metabolism
- In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: Key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH
- (2011) Johanna Chiche et al. INTERNATIONAL JOURNAL OF CANCER
- CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
- (2011) R. Le Floch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
- (2011) D. A. Chan et al. Science Translational Medicine
- Genome-Scale Metabolic Modeling Elucidates the Role of Proliferative Adaptation in Causing the Warburg Effect
- (2011) Tomer Shlomi et al. PLoS Computational Biology
- The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein
- (2010) Matthew J. Ovens et al. BIOCHEMICAL JOURNAL
- Sequential therapy in renal cell carcinoma
- (2010) Bernard Escudier et al. CANCER
- pH control mechanisms of tumor survival and growth
- (2010) Scott K. Parks et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7–10
- (2009) Matthew J. Ovens et al. BIOCHEMICAL JOURNAL
- High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
- (2009) Maria V Yusenko et al. BMC CANCER
- Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
- (2009) R. Beroukhim et al. CANCER RESEARCH
- CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
- (2009) W Schneiderhan et al. GUT
- E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation
- (2009) A. Almeida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
- (2008) M. L. Nickerson et al. CLINICAL CANCER RESEARCH
- Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo
- (2008) Jonas Sjölund et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
- (2008) B. Clem et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started